Topamax is used to treat several different types of seizures alone and in combination with other seizure medicines.

Topamax is approved by the Food and Drug Administration (FDA) for:

• partial-onset seizures in adults and children ages 2-16 years
• generalized tonic-clonic seizures in adults and children ages 2-16 years
• seizures associated with Lennox-Gastaut syndrome in people 2 years of age and older

Topamax is approved by the Food and Drug Administration (FDA) as initial monotherapy for patients 10 years of age and older with partial-onset or primary generalized tonic-clonic seizures.

Partial seizures are seizures that begin in a limited area of the brain. Sometimes these seizures spread throughout the brain.

Generalized seizures begin throughout the brain.

Topamax is also effective for other childhood epilepsies.